Aaron Kesselheim

@akesselheim

Professor of Medicine, Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital

Boston
portalresearch.org
Dołączył luty 2009
25 zdjęć lub filmów Zdjęcia i filmy

Tweety

Zablokowano @akesselheim

Czy na pewno chcesz zobaczyć te Tweety? Zobaczenie Tweetów nie odblokuje @akesselheim

  1. 8 gru

    Stand up for the scientific process — a public statement in advance of tomorrow’s Senate hearing — with Peter Lurie of and dozens of others

    2 odpowiedzi 5 podanych dalej 13 polubionych
    Cofnij
  2. 7 gru

    This is fantastic news

    SCOOP: Joe Biden has selected Rochelle Walensky, the chief of infectious diseases at Massachusetts General Hospital, to run the Centers for Disease Control and Prevention.
    10 podanych dalej 56 polubionych
    Cofnij
  3. podał/a dalej
    7 gru

    SCOOP: Joe Biden has selected Rochelle Walensky, the chief of infectious diseases at Massachusetts General Hospital, to run the Centers for Disease Control and Prevention.

    49 odpowiedzi 605 podanych dalej 2 115 polubionych
    Cofnij
  4. podał/a dalej
    4 gru

    Medicare spending on inhalers increased $2b — 44% — in recent years, underscoring how a lack of generic competition fosters high prices, according to a new study by .

    1 odpowiedź 6 podanych dalej 15 polubionych
    Cofnij
  5. 21 lis

    Check out this excellent tweet thread on public funding of drug innovation!

    Happy to see the cite our investigation, Revisiting the National Institutes of Health Fair Pricing Condition in . 1/5
    Pokaż ten wątek
    4 podane dalej 10 polubionych
    Cofnij
  6. podał/a dalej
    24 paź

    Young people will lead...their civic engagement on a range of issues is our present and our future. Listen, support, process, challenge, love. Nurture their sense of belonging and purpose. It is the bridge to progress.

    Young people are showing up like woah
    Pokaż ten wątek
    4 podane dalej 11 polubionych
    Cofnij
  7. 21 paź

    Three weeks ago, over 160 medical and regulatory science experts signed on to our open letter urging Commissioner Hahn to defend FDA scientists’ independence and . Now...How the F.D.A. Stood Up to the President - The New York Times

    3 podane dalej 20 polubionych
    Cofnij
  8. 20 paź

    New article with in Vanderbilt Law Review discussing recent prescription drug importation proposals and how importation could be effectively implemented for generic drugs. It's long!

    3 podane dalej 5 polubionych
    Cofnij
  9. podał/a dalej
    14 paź

    ⁦⁩ ⁦⁩ you are making an impact. FDA pushes back on Trump administration attempt to rebrand ‘emergency authorization’ - POLITICO

    7 podanych dalej 27 polubionych
    Cofnij
  10. podał/a dalej
    10 paź

    If you want to get a summary of all good things happening at , join the mailing list here:

    1 odpowiedź 5 podanych dalej 10 polubionych
    Cofnij
  11. 6 paź

    Thanks to the over 160 experts in medicine and regulatory science who have signed our open letter to . But political micromanagement continues, as seen in this report: . Add your name here:

    6 podanych dalej 12 polubionych
    Cofnij
  12. 30 wrz

    House of Representatives hearings highlighting work led by on Copaxone costs and product hopping — one of my favorite papers from the group this past year!

    much needed spotlight on Teva’s Copaxone: the poster child of product hopping - costing the U.S. upwards of $6.5B and Celgene’s/BMY's Revlimid - generic companies tried 13 times to gain access to samples of the drug to run the nec. studies, all denied
    Pokaż ten wątek
    5 podanych dalej 19 polubionych
    Cofnij
  13. podał/a dalej
    29 wrz

    Increase transparency at the FDA: We need sunlight to fight the pandemic via Fantastic. Detail on FDA & company disclosure impressive. I love preemptive rebuttal of claims about confidential business information. Well done

    12 podanych dalej 21 polubionych
    Cofnij
  14. 29 wrz

    Top FDA Vaccine Official Says Vaccine Guidance May Never Be Released - - reporting from Concerned? Read our open letter from experts in medicine/regulatory science to Cmr. Hahn and sign on:

    3 podane dalej 12 polubionych
    Cofnij
  15. 29 wrz

    New Op-Ed in with led by phenomenal student -- how better transparency can help us through the COVID19 crisis:

    1 odpowiedź 14 podanych dalej 33 polubione
    Cofnij
  16. 29 wrz

    Coverage in: RAPS: Newsweek: CNN:

    2 podane dalej 2 polubione
    Pokaż ten wątek
    Pokaż ten wątek
    Cofnij
  17. 29 wrz

    3 days ago, over two dozen experts in regulatory science and medicine outlined ways to protect FDA vaccine decisionmaking from undue political influence. Now over 100 have signed on to the letter! Read the letter and add your support here:

    1 odpowiedź 13 podanych dalej 16 polubionych
    Pokaż ten wątek
    Pokaż ten wątek
    Cofnij
  18. 25 wrz

    As experts in regulatory science and medicine, we support the independence of scientists in decisionmaking related to vaccines. Read our letter to Commissioner Stephen Hahn & sign on to a call to from political influence:

    4 odpowiedzi 24 podane dalej 41 polubionych
    Cofnij
  19. 25 wrz

    Featured on this week's Open Source with Christopher Lydon podcast ("Warped Speed") -- we talk about the search for a Covid19 vaccine, and then the podcast also covers distribution and cost issues

    3 podane dalej 11 polubionych
    Cofnij
  20. 15 wrz

    Up is down -- in , Jerry Avorn and I discuss early Covid vaccine authorization, the implications of FDA guidance and the recent industry pledge, and the public’s eroding trust in one of the most important aspects of US science policy.

    21 podanych dalej 43 polubione
    Cofnij

@akesselheim nie wysyłał/a jeszcze żadnego Tweeta.

Wydaje się, że ładowanie zajmuje dużo czasu.

Twitter jest przeciążony lub wystąpił chwilowy problem. Spróbuj ponownie lub sprawdź status Twittera, aby uzyskać więcej informacji.

    Może Ci się też spodobać

    ·